Systematic Review
Published on 28 Jan 2022
Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
in Thoracic Oncology
![Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis](https://www.frontiersin.org/files/myhome article library/810580/810580_Thumb_400.jpg)
- 7,066 views
- 1 citation